US Stock MarketDetailed Quotes

Sutro Biopharma (STRO)

Watchlist
  • 28.150
  • +1.670+6.31%
Trading Jun 12 13:49 ET
466.46MMarket Cap-1.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sutro Biopharma (STRO) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Focuses on developing site-specific and novel-format Antibody-Drug Conjugates (ADCs)14.52M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States102.48M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.48%
Sample Name
Sample Code
 +0.65%
Sample Name
Sample Code
 -1.96%
4
ProShares Ultra Energy
DIG
-2.42%
5
VanEck Oil Services ETF
OIH
-2.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +10.48%
Sample Name
Sample Code
 +8.86%
4
Qifu Technology
QFIN
+5.78%
5
NetEase
NTES
+5.76%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -